This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the proposed study is to visualize which regions of the brain show different metabolic activity in schizotypal patients and schizophrenic patients compared to normal controls while they are engaged in a carefully defined visual-spatial working memory task. This will help us to better understand the neurobiological mechanisms of cognitive impairment in schizophrenia. Schizotypal patients are a particularly informative group to study to understand the cognitive impairments in schizophrenia since they share genetic and phenomenological features with schizophrenia, yet do not have concurrent psychotic symptoms which might confound interpretation of the regional brain metabolic activity associated with cognitive impairment. SPD patients also typically provide a population that has not been exposed to neuroleptic medications, the chronic effects of which, could introduce an artifact in studies of brain activity. The proposed study will use fMRI to record regional cerebral blood flow (rCBF), a measure of cerebral metabolic activity, in 24 SPD patients 24 schizophrenic patients and 48 normal controls as they carry out a visual-spatial working memory task. Hypothesis: We expect that schizophrenia spectrum patients (SPD and SCZ patents) will have a functional impairment in BA 9/46 and will activate this region less strongly than healthy controls in carrying out a visuospatial working memory task. To compensate, they will recruit other cortical areas, including BA 10, in particular. However, SCZ patients may not be able to activate BA 10 as effectively as SPD patients, likely because of a greater degree of pathology in the frontal lobe.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000071-46
Application #
7953679
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2009-03-01
Project End
2009-07-31
Budget Start
2009-03-01
Budget End
2009-07-31
Support Year
46
Fiscal Year
2009
Total Cost
$1,468
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Kattan, Meyer; Bacharier, Leonard B; O'Connor, George T et al. (2018) Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in Pregnancy. J Allergy Clin Immunol Pract 6:1596-1603.e6
Coplan, Jeremy D; Webler, Ryan; Gopinath, Srinath et al. (2018) Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQ. J Affect Disord 229:1-13
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Chen, Teresa K; Appel, Lawrence J; Grams, Morgan E et al. (2017) APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Arterioscler Thromb Vasc Biol 37:1765-1769
Ku, Elaine; Gassman, Jennifer; Appel, Lawrence J et al. (2017) BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol 28:671-677
Anderegg, Nanina; Johnson, Leigh F; Zaniewski, Elizabeth et al. (2017) All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1:S31-S40
Gern, James E; Calatroni, Agustin; Jaffee, Katy F et al. (2017) Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopy. J Allergy Clin Immunol 140:836-844.e7
Abdallah, Chadi G; Jackowski, Andrea; Salas, Ramiro et al. (2017) The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder. Neuropsychopharmacology 42:1739-1746

Showing the most recent 10 out of 869 publications